Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective

Journal of the American Pharmacists Association

Volumn 50, Issue 2, 2010, Pages 148-157

  Nacopoulos, Alkiviadis G ^a   Lewtas, Andrea J ^a   Ousterhout, Maria M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Pharmacy services; Syringe access; Syringe exchange programs

Indexed keywords

DRUG ABUSE; HUMAN; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PREVENTIVE HEALTH SERVICE; PROFESSIONAL STANDARD; REVIEW; STANDARD; STATISTICS; SUBSTANCE ABUSE; SYRINGE; UNITED STATES;

HUMANS; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PHARMACIES; PHARMACISTS; PROFESSIONAL ROLE; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; UNITED STATES;

EID: 77952505982     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09178     Document Type: Article

References (50)

1. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2006 disease profile. Accessed at www.cdc.gov/nchhstp/Publications/docs/2006- Disease-Profile-508-FINAL.pdf, September 24, 2009.
2. Centers for Disease Control and Prevention. A comprehensive approach: preventing blood-borne infections among injection drug users. Accessed at www.cdc.gov/IDU/pubs.htm, September 24, 2009.
3. Ferrini R. American College of Preventive Medicine public policy on needle-exchange programs to reduce drug-associated morbidity and mortality. Am J Prev Med. 2000;18:173-5.
4. Battles HB, Rowe KA, Ortega-Peluso C, et al. Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP). J Urban Health. 2009;86:946-50.
5. World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDs among injecting drug users. Accessed at www.who.int/hiv/pub/idu/pubidu/en, September 24, 2009.
6. Centers for Disease Control and Prevention. Syringe exchange programs. Accessed at www.cdc.gov/idu/facts/AED-IDU-SYR.pdf, September 24, 2009.
7. Henry J. Kaiser Family Foundation. Sterile syringe exchange programs, 2005. Accessed at www.statehealthfacts.org/comparemapdetail.jsp?ind=566&cat= 11&sub=130&yr=16&typ=5, September 24, 2009.
8. North American Syringe Exchange Program. U.S. Syringe Exchange Program Database. Accessed at www.nasen.org/programs, October 20, 2009.
9. Brahmbhatt H, Bigg D, Strathdee SA. Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998. J Urban Health. 2000;77:346-58.
10. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154(12 suppl):S70-7.
11. Medical News Today. House passes spending bill; amendment to block removal of needle exchange funding ban defeated. Accessed at www.medicalnewstoday.com/articles/158985.php, October 16, 2009.
12. Library of Congress. 111th Congress, 1st session, H.R.3293. Accessed at http://thomas.loc.gov/cgi-bin/query/C?c111:./temp/~c111rNfHHd, October 16, 2009.
13. Tapestry Health Systems. House votes to end federal funding ban for syringe exchange. Accessed at http://teens.tapestryhealth.org/index.php/2009/12/ house-votes-to-end-federal-funding-ban-for-syringe-exchange, January 11, 2010.
14. Dillon P. Needle exchange ban lifted; ball's in Rell's court. Accessed at www.newhavenindependent.org/HealthCare/archives/2009/12/needle-exchange-1.php, January 11, 2010.
15. Aids Action. AIDS Action applauds Congress for historic end to twenty year ban on the use of federal funds for syringe exchange. Accessed at www.aidsaction.org/news-room-main-menu-182/press-releases-mainmenu-342/ 45-press-releases-2009-/553-washington-december-13-2009, January 11, 2010.
16. Turnberg WL, Kones TS. Community syringe collection and disposal policies in 16 states. J Am Pharm Assoc. 2002;42(suppl 2):S99-104.
17. Centers for Disease Control and Prevention. State and local policies regarding IDUs' access to sterile syringes. Accessed at www.cdc.gov/idu/facts/ aed-idu-pol.pdf, September 28, 2009.
18. Temple University Beasley School of Law. Law, policy & public health at Temple University's Beasley School of Law: non-prescription access to sterile syringes. Accessed at www.temple.edu/lawschool/phrhcs/otc.htm, October 23, 2009.
19. Riley ED, Wu AW, Junge B, et al. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse. 2002;28:497-511.
20. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005;40:1681-96.
21. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr Hum Retrovirol. 2001;28:237-78.
22. Hagan H, Des Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. Am J Public Health. 1995;85:1531-7.
23. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329-41.
24. Ouellet L, Dezheng H, Bailey S. HIV risk practices among needle exchange users and nonusers in Chicago. Epidemiology and Social Science. 2004;37:1187-96.
25. Riley ED, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000;24:57-61.
26. Hagan H, McGough JP, Thiede H, et al. Volunteer bias in non-randomized evaluations of the efficacy of needle-exchange programs. J Urban Health. 2000;77:103-11.
27. Fischer DG, Reynolds GL, Harbke CR. Selection effect of needle exchange in Anchorage, Alaska. J Urban Health. 2002;79:128-35.
28. Holtzman D, Barry V, Ouellet LJ, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med. 2009;49:68-73.
29. Neaigus A, Zhao M, Gyarmathy A, et al. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are Illegal. J Urban Health. 2008;85:309-22.
30. Longshore D, Bluthenthal RN, Stein MD. Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Educ Prev. 2001;13:78-90.
31. Bailey SL, DeZheng H, Garfein RS, et al. The use of needle exchange by young injection drug use. J Acquir Immune Defic Syndr. 2003;34:67-70.
32. Huo D, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago. J Acquir Immune Defic Syndr. 2007;45:108-14.
33. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77:369-82.
34. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev. 2003;15:257-68.
35. Gibson DR, Brand R, Ander K, et al. Two- to sixfold decreased odds of hiv risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002;31:237-42.
36. Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605-11.
37. Huo D, Ouellet LJ. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sex Transm Dis. 2009;36:35-40.
38. Masson CI, Sorensen JL, Perlman DC, et al. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007;19:91-110.
39. Braine N, Des Jarlais DC, Ahmad S, et al. Long-term effects of syringe exchange on risk behavior and HIV prevention. AIDS Educ Prev. 2004;16:264-75.
40. Centers for Disease Control and Prevention. Pharmacy sales of sterile syringes. Accessed at www.cdc.gov/idu/facts/aed-idu-phar.pdf, September 28, 2009.
41. Taussig J, Junge B, Burris S, et al. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002;42(suppl 2):S40-5.
42. Taussig JA, Weinstein B, Burris S, et al. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14(suppl 1):S47-51.
43. Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc. 2002;42(suppl 2):S52-7.
44. Rich JD, Martin EG, Macalino GE, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc. 2002;42(suppl 2):S58-61.
45. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002;42(suppl 2):S46-51.
46. Deibert RJ, Goldbaum G, Parker TR. Increased access to unrestricted pharmacy sales of syringes in Seattle-King county, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006;96:1347-53.
47. Jones TS, Coffin PO. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc. 2002;42(6 suppl 2):S6-9.
48. Pouget ER, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005;39:471-7.
49. Burris S, Vernick JS, Ditzler A, et al. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc. 2002;42(suppl 2):S13-8.
50. Wolfe T, Amelunxen V, Torres D, et al. Encouraging pharmacy sale of syringes to injection drug users in New Mexico. J Am Pharm Assoc. 2002;42(suppl 2):S32-3.